Filter Results
:
(230)
Show Results For
-
All HBS Web
(497)
- Faculty Publications (230)
Show Results For
-
All HBS Web
(497)
- Faculty Publications (230)
- April 1993 (Revised October 1995)
- Case
ALZA and Bio-Electro Systems (A): Technological and Financial Innovation
By: Josh Lerner and Peter Tufano
To develop the next generation of risky products, ALZA, a mature and profitable biotechnology firm specializing in drug delivery systems, must raise $40 million. Organizational constraints and competitive concerns demand that the work be done inside the firm. However,...
View Details
Keywords:
Risk and Uncertainty;
Technological Innovation;
Business Subsidiaries;
Decision Choices and Conditions;
Corporate Finance;
Biotechnology Industry;
Biotechnology Industry
Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (A): Technological and Financial Innovation." Harvard Business School Case 293-124, April 1993. (Revised October 1995.)
- 1989
- Chapter
Collaborative Product Development and the Market for Know-How: Strategies and Structures in the Biotechnology Industry
By: Gary P. Pisano and Paul Mang
Keywords:
Product Development;
Innovation Strategy;
Knowledge Management;
Industry Structures;
Biotechnology Industry
Pisano, Gary P., and Paul Mang. "Collaborative Product Development and the Market for Know-How: Strategies and Structures in the Biotechnology Industry." In Research on Technological Innovation, Management, and Policy. Vol. 4, edited by Richard S. Rosenbloom and Robert A. Burgelman. Greenwich, CT: JAI Press, 1989.
- December 1992 (Revised September 1996)
- Case
ImmuLogic Pharmaceutical Corporation (Abridged)
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are...
View Details
Keywords:
Decisions;
Initial Public Offering;
Entrepreneurship;
Going Public;
Business Startups;
Biotechnology Industry;
Biotechnology Industry;
United States
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Abridged)." Harvard Business School Case 293-087, December 1992. (Revised September 1996.)
- October 1992 (Revised November 1997)
- Case
ImmuLogic Pharmaceutical Corporation (A): March 1991
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems...
View Details
Keywords:
Decisions;
Entrepreneurship;
Venture Capital;
Banks and Banking;
Initial Public Offering;
Going Public;
Perspective;
Valuation;
Biotechnology Industry;
Biotechnology Industry
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
- May 1992 (Revised February 1996)
- Teaching Note
Nucleon, Inc., Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-041).
View Details
Keywords:
Biotechnology Industry
- March 1992 (Revised June 2005)
- Teaching Note
Monsanto's March into Biotechnology (A), Teaching Note
By: Dorothy Leonard-Barton and Alistair D. Williamson
Teaching Note for (9-690-009).
View Details
Keywords:
Biotechnology Industry
- March 1992
- Case
Amgen, Inc.: Planning the Unplannable
By: Nitin Nohria
By the early 1990s, Amgen--a pharmaceutical company started little over a decade ago as Applied Molecular Genetics--was within range of becoming a billion-dollar company. With two extremely successful biotechnology drugs on the market, Amgen stood as the largest and...
View Details
Keywords:
Growth and Development Strategy;
Strategic Planning;
Success;
Risk and Uncertainty;
Pharmaceutical Industry
Nohria, Nitin. "Amgen, Inc.: Planning the Unplannable." Harvard Business School Case 492-052, March 1992.
- February 1992
- Case
U.S. Biotechnology Industry in 1987 (Abridged)
By: Dorothy Leonard-Barton and Alistair D. Williamson
Leonard-Barton, Dorothy, and Alistair D. Williamson. "U.S. Biotechnology Industry in 1987 (Abridged)." Harvard Business School Case 792-077, February 1992.
- November 1991
- Case
Monsanto's March into Biotechnology (B)
Monsanto has yet to receive FDA approval for BST, a growth hormone for cows. Anti-BST groups have successfully lobbied Wisconsin and Minnesota, major milk producing states, to ban milk from BST-injected cows; the FDA has charged Monsanto with improperly promoting BST...
View Details
Keywords:
Animal-Based Agribusiness;
Safety;
Food;
Governing Rules, Regulations, and Reforms;
Law Enforcement;
Conflict and Resolution;
Research and Development;
Technology;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Minnesota;
Wisconsin
Leonard, Dorothy A. "Monsanto's March into Biotechnology (B)." Harvard Business School Case 692-066, November 1991.
- November 1991
- Case
Monsanto's March into Biotechnology (B) (Abridged)
By: Dorothy Leonard-Barton and Alistair D. Williamson
Keywords:
Biotechnology Industry
Leonard-Barton, Dorothy, and Alistair D. Williamson. "Monsanto's March into Biotechnology (B) (Abridged)." Harvard Business School Case 692-067, November 1991.
- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)...
View Details
Keywords:
Factories, Labs, and Plants;
Entrepreneurship;
Health Testing and Trials;
Rights;
Product Development;
Production;
Partners and Partnerships;
Research and Development;
Biotechnology Industry
Pisano, Gary P. "Nucleon, Inc." Harvard Business School Case 692-041, November 1991. (Revised April 1994.)
- Article
The Governance of Innovation: Vertical Integration and Collaborative Arrangements in the Biotechnology Industry
By: Gary P. Pisano
Pisano, Gary P. "The Governance of Innovation: Vertical Integration and Collaborative Arrangements in the Biotechnology Industry." Research Policy 20, no. 3 (June 1991): 237–249.
- September 1990 (Revised November 1990)
- Case
DNAP: Looking to the Nineties
By: Ray A. Goldberg
Goldberg, Ray A. "DNAP: Looking to the Nineties." Harvard Business School Case 591-032, September 1990. (Revised November 1990.)
- June 1990 (Revised April 1993)
- Teaching Note
Novo Industri A/S--1981, Teaching Note
By: W. Carl Kester
Teaching Note for (9-286-084).
View Details
- January 1990 (Revised October 1993)
- Case
Monsanto's March into Biotechnology (A)
By: Gary P. Pisano
Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional...
View Details
Pisano, Gary P. "Monsanto's March into Biotechnology (A)." Harvard Business School Case 690-009, January 1990. (Revised October 1993.)
- September 1989 (Revised December 1989)
- Case
Beef Hormone Trade Dispute
By: Ray A. Goldberg
Keywords:
Trade;
Agribusiness;
Food;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Goldberg, Ray A. "Beef Hormone Trade Dispute." Harvard Business School Case 590-035, September 1989. (Revised December 1989.)
- Article
Using Equity Participation to Support Exchange: Evidence from the Biotechnology Industry
By: Gary P. Pisano
Pisano, Gary P. "Using Equity Participation to Support Exchange: Evidence from the Biotechnology Industry." Journal of Law, Economics & Organization 5, no. 1 (Spring 1989): 109–126.
- October 1988 (Revised November 1988)
- Case
Du Pont: Biotechnology in Agricultural Products
By: Ray A. Goldberg
Goldberg, Ray A. "Du Pont: Biotechnology in Agricultural Products." Harvard Business School Case 589-058, October 1988. (Revised November 1988.)
- 1988
- Chapter
Joint Ventures and Collaboration in the Biotechnology Industry
By: Gary P. Pisano, W. Shan and David Teece
- November 1986
- Case
Amgen
By: Ray A. Goldberg
Keywords:
Biotechnology Industry
Goldberg, Ray A. "Amgen." Harvard Business School Case 587-095, November 1986.